Ensysce Biosciences Inc (ENSC)

Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	21.16%1.16	0.96	1.88	0.49	1.37
	17.30%3.74	4.52	4.66	4.23	3.12
Research and Development	26.15%2.47	3.35	3.61	2.95	1.92
Operating Income/Loss	27.67%-2.58	-3.56	-2.78	-3.74	-1.75
Nonoperating Income/Loss	5.18%0.01	0.01	0.01	0.01	0.02
	27.71%-2.57	-3.56	-2.77	-3.73	-1.73
Available To Common Stockholders, Basic	27.72%-2.57	-3.56	-2.77	-3.73	-1.73
Attributable To Noncontrolling Interest	-0.00	-	-0.00	-	-0.00
Basic Average Shares	90.60%13.04	6.84	-	2.89	2.20
Diluted Average Shares	90.60%13.04	6.84	-	2.89	2.20
Basic Earnings Per Share	61.54%-0.20	-0.52	-	-1.29	-0.79
Diluted Earnings Per Share	61.54%-0.20	-0.52	-	-1.29	-0.79